(RTTNews) - PhenomeX Inc. (CELL) Monday reported second-quarter net loss of $50.2 million or $0.51 per share, compared to $25.7 million or $0.38 per share last year.
Revenue was $14.1 million for the second quarter, comprised of $12.1 million of Optofluidics revenue and $2.0 million of Proteomics revenue. Platform revenue was $6.5 million and recurring revenue was $7.3 million in the second quarter of 2023.
Analysts polled by Thomson Reuters expected a loss of $0.32 per share on revenues of $17.35 million.
Looking ahead, PhenomeX reiterates full year 2023 revenue to be in the range of $75 to $85 million dollars.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
